Showing results (211-220 of 311) with videos related to

Sort By:
Pageof 32
Archivos Del Instituto De Cardiologia De Mexico|March 1, 1989
[Study of renal function by creatinine clearance]H Arcila Herrera, L Montero Cervantes, N Rivero Cárdenas, et al.
Translational Oncology|December 8, 2017
Chimeric HCMV/HSV-1 and Δγ<sub>1</sub>34.5 oncolytic herpes simplex virus elicit immune mediated antigliomal effect and antitumor memoryMohammed G Ghonime, Josh Jackson, Amish Shah, et al.
International Journal of Radiation Oncology, Biology, Physics|September 5, 2007
Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery aloneStephen M Sawrie, Barton L Guthrie, Sharon A Spencer, et al.
Cancers|October 16, 2025
Challenges and Opportunities in High-Grade Glioma Management and Imaging-Based Response Monitoring During Novel ImmunotherapiesCarlos A Gallegos, Benjamin P Lee, Benjamin B Kasten, et al.
Protein Science : a Publication of the Protein Society|August 25, 2025
Inhibitor-induced dimerization mediates lufotrelvir resistance in mutants of SARS-CoV-2 3C-like proteaseGuanyu Wang, Felipe Venegas, Andres Rueda, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 9, 1999
Effect of cardiopulmonary bypass and heparin on plasma levels of Lp(a) and Apo(a) fragmentsV Mooser, F Tinguely, P Fontana, et al.
The Journal of Biological Chemistry|September 24, 2002
Protein kinase C isoform antagonism controls BNaC2 (ASIC1) functionBakhrom K Berdiev, Jiazeng Xia, Biljana Jovov, et al.
Chemico-Biological Interactions|January 24, 2023
Antioxidant activity and enzymatic of lichen substances: A study based on cyclic voltammetry and theoreticalOsvaldo Yañez, Manuel I Osorio, Edison Osorio, et al.
Nature Communications|January 30, 2025
Oncolytic reprogramming of tumor microenvironment shapes CD4 T-cell memory via the IL6ra-Bcl6 axis for targeted control of glioblastomaJeffrey M Grimes, Sadashib Ghosh, Shamza Manzoor, et al.
Journal of Neuro-Oncology|April 20, 2022
High-dose methotrexate and rituximab induction regimen in immunocompetent patients with primary CNS lymphoma: a retrospective single-center study of survival predictorsAndrew B DeAtkine, Moaaz Abdelrashid, Zach Tucker, et al.
Pageof 32